Loading...
PhD Irena Oblak

PhD Irena Oblak
no.: 20052 source: ARIS

researcher – active in research organisation
Foreign language skills
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
Radiotherapy, oncology, head and neck cancer, Hb
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
317.26
A''
2.57
A'
38.65
A1/2
66.95
CI10
700
CImax
165
h10
16
A1
0.92
A3
1.34
Data for the last 5 years (citations for the last 10 years) on July 12, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 59  843  769  13.03 
Scopus 41  940  867  21.15 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:20%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. V3-2322  Framework development for evidence-based, sustainable implementation of organised population-based screening for prostate cancer in Slovenia (PETER)   2023 - 2024  PhD Irena Oblak  3,138 
2. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2021 - 2024  PhD Gregor Serša  6,839 
3. J3-2528  Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors   2020 - 2023  PhD Maja Čemažar  3,201 
4. V3-2032  The impact of COVID-19 on the cancer management in Slovenia   2020 - 2022  PhD Tina Žagar  2,099 
5. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   2018 - 2021  PhD Gregor Serša  3,540 
6. J3-8202  Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost   2017 - 2020  PhD Maja Čemažar  3,578 
7. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   2016 - 2018  PhD Primož Strojan  4,302 
8. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2017  PhD Gregor Serša  5,140 
9. J3-4211  Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems   2011 - 2014  PhD Gregor Serša  6,516 
10. J3-4259  Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters   2011 - 2014  PhD Maja Čemažar  5,918 
11. J3-6044  Nove poti zdravljenja pljučnega raka (Slovene)   2004 - 2007  PhD Matjaž Zwitter  2,789 
12. J3-4308  Napovedni pomen katepsinov in stefinov pri napredovalnem karcinomu glave in vratu zdravljenem s konkomitantno radiokemoterapijo (Slovene)   2002 - 2005  PhD Alojz Šmid  2,065 
13. J3-4176  Predklinične raziskave elektrogenske terapije v onkologiji (Slovene)   2002 - 2005  PhD Maja Čemažar  4,863 
14. J3-3021  Multimodality treatment for lung cancer   2002 - 2004  PhD Matjaž Zwitter  1,806 
ARIS research and infrastructure programmes Legend
source: ARIS
We were not given permission by the researcher to publish data.
Views history
Favourite